Regen Appoints President
This article was originally published in Scrip
Regen BioPharma, Inc., a publicly traded biotechnology company, has appointed Dr. Harry Lander president. Lander brings extensive experience as both a researcher and administrator to the company and has served in these positions at Cornell University and Sidra Medical and Research Centre in Qatar.
Register for our free email digests: